Immunome, Inc. - Common Stock (NQ:IMNM)
Price and Volume
Detailed Quote| Volume | 551,261 |
| Open | 24.68 |
| Bid (Size) | 24.85 (200) |
| Ask (Size) | 24.90 (800) |
| Prev. Close | 24.50 |
| Today's Range | 24.29 - 25.18 |
| 52wk Range | 5.150 - 27.65 |
| Shares Outstanding | 87,012,328 |
| Dividend Yield | N/A |
Top News
More News
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 05, 2026
From Immunome, Inc.
Via Business Wire
Performance
| YTD |
+19.5%
|
+19.5%
|
| 1 Month |
+20.9%
|
+20.9%
|
| 3 Month |
+51.3%
|
+51.3%
|
| 6 Month |
+157.5%
|
+157.5%
|
| 1 Year |
+121.7%
|
+121.7%
|
More News
Read More
Where Immunome Stands With Analysts ↗
September 22, 2025
Via Benzinga
From Immunome, Inc.
Via Business Wire
From Immunome, Inc.
Via Business Wire
Immunome to Present at 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
From Immunome, Inc.
Via Business Wire
Immunome Announces Pricing of Public Offering of Common Stock
December 16, 2025
From Immunome, Inc.
Via Business Wire
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
December 16, 2025
From Equity Insider
Via GlobeNewswire
Why Immunome Stock Surged Today ↗
December 15, 2025
Via The Motley Fool
Immunome Announces Proposed Public Offering of Common Stock
December 15, 2025
From Immunome, Inc.
Via Business Wire
Which stocks are gapping on Monday? ↗
December 15, 2025
Via Chartmill
Why Is IMNM Stock Rising Today? ↗
December 15, 2025
Via Stocktwits
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2025
From Immunome, Inc.
Via Business Wire
Immunome to Present at Upcoming Investor Conferences
November 25, 2025
From Immunome, Inc.
Via Business Wire
Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update
November 06, 2025
From Immunome, Inc.
Via Business Wire
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 04, 2025
From Immunome, Inc.
Via Business Wire
From Immunome, Inc.
Via Business Wire
From Immunome, Inc.
Via Business Wire
Via Benzinga
Infinimmune Announces Research Collaboration with Immunome
September 18, 2025
From Infinimmune
Via Business Wire
Frequently Asked Questions
Is Immunome, Inc. - Common Stock publicly traded?
Yes, Immunome, Inc. - Common Stock is publicly traded.
What exchange does Immunome, Inc. - Common Stock trade on?
Immunome, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immunome, Inc. - Common Stock?
The ticker symbol for Immunome, Inc. - Common Stock is IMNM on the Nasdaq Stock Market
What is the current price of Immunome, Inc. - Common Stock?
The current price of Immunome, Inc. - Common Stock is 24.88
When was Immunome, Inc. - Common Stock last traded?
The last trade of Immunome, Inc. - Common Stock was at 02/10/26 03:20 PM ET
What is the market capitalization of Immunome, Inc. - Common Stock?
The market capitalization of Immunome, Inc. - Common Stock is 2.16B
How many shares of Immunome, Inc. - Common Stock are outstanding?
Immunome, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>